Postponement of AB Science Annual General Shareholders’ meeting
22/05/2020 – AB Science announces the postponement of its annual general shareholders’ meeting
Live webcast on masitinib in combination with isoquercetine for the treatment of COVID-19 on Monday May 11, 2020
07/05/2020 – AB Science will host a live webcast on masitinib in combination with isoquercetin for the treatment of COVID-19 on Monday May 11, 2020
Presentation of the results from the Phase 3 AB07015 study in severe asthma at the EAACI 2020 Annual Congress
07/05/2020 – AB Science will present results from its Phase 3 study in severe asthma at the EEACI 2020 Annual Congress
Authorization by ANSM to initiate Phase 2 study evaluating masitinib in combination with isoquercetin for the treatment of COVID-19
06/05/2020 – AB Science granted authorization by ANSM to initiate Phase 2 study evaluating masitinib in combination with isoquercetin for the treatment of COVID-19